Abstract
There are currently unprecedented opportunities to treat rheumatoid arthritis using well-designed, highly effective, targeted therapies. This will result in a substantial improvement in the outcome of this disorder for most affected individuals, if they can afford these therapies. Yet our lack of understanding of the basic mechanisms that initiate and sustain this disease remains a major obstacle in the search for a definitive cure. It is possible, if not likely, that our best approach will be to identify individuals at risk and devise reliable, safe methods of preventing the disease before it occurs. The means to do this are currently unknown but should serve as a major focus of research.
MeSH Terms
Arthritis, Rheumatoid/etiology,prevention & control,therapy
Humans
Synovitis/etiology,prevention & control,therapy
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
El-Gabalawy Hani D
Intramural Research Program, National Institute of Arthritis and Musculoskeletal and Skin Diseases, Bethesda, MD 20892, USA.
Lipsky Peter E
References (18)
18 references, click to expand
-
Arthritis provoked by linked T and B cell recognition of a glycolytic enzyme.
Science. 1999 Nov 26;286(5445):1732-5
PMID: 10576739
-
Altered memory T cell differentiation in patients with early rheumatoid arthritis.
J Immunol. 1999 Jul 1;163(1):491-9
PMID: 10384153
-
Retrotransposable L1 elements expressed in rheumatoid arthritis synovial tissue: association with genomic DNA hypomethylation and influence on gene expression.
Arthritis Rheum. 2000 Dec;43(12):2634-47
PMID: 11145021
-
Rheumatoid arthritis associated autoantibodies in patients with synovitis of recent onset.
Arthritis Res. 2000;2(3):236-43
PMID: 11056669
-
AMD3100, a potent and specific antagonist of the stromal cell-derived factor-1 chemokine receptor CXCR4, inhibits autoimmune joint inflammation in IFN-gamma receptor-deficient mice.
J Immunol. 2001 Oct 15;167(8):4686-92
PMID: 11591799
-
TRANCE/RANKL knockout mice are protected from bone erosion in a serum transfer model of arthritis.
Am J Pathol. 2001 Nov;159(5):1689-99
PMID: 11696430
-
How antibodies to a ubiquitous cytoplasmic enzyme may provoke joint-specific autoimmune disease.
Nat Immunol. 2002 Apr;3(4):360-5
PMID: 11896391
-
Immunohistological features in the synovium obtained from clinically uninvolved knee joints of patients with rheumatoid arthritis.
Br J Rheumatol. 1989 Aug;28(4):287-92
PMID: 2787183
-
Positive selection in autoimmunity: abnormal immune responses to a bacterial dnaJ antigenic determinant in patients with early rheumatoid arthritis.
Nat Med. 1995 May;1(5):448-52
PMID: 7585093
-
Genetic bias in immune responses to a cassette shared by different microorganisms in patients with rheumatoid arthritis.
J Clin Invest. 1997 Aug 1;100(3):658-63
PMID: 9239413
-
Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies.
J Clin Invest. 1998 Jan 1;101(1):273-81
PMID: 9421490
-
Prediction of insulin-dependent diabetes mellitus in siblings of children with diabetes. A population-based study. The Childhood Diabetes in Finland Study Group.
J Clin Invest. 1998 Jan 15;101(2):327-36
PMID: 9435304
-
Identification of cell types responsible for bone resorption in rheumatoid arthritis and juvenile rheumatoid arthritis.
Am J Pathol. 1998 Apr;152(4):943-51
PMID: 9546355
-
Human parvovirus B19 as a causative agent for rheumatoid arthritis.
Proc Natl Acad Sci U S A. 1998 Jul 7;95(14):8227-32
PMID: 9653169
-
Asymptomatic synovitis precedes clinically manifest arthritis.
Arthritis Rheum. 1998 Aug;41(8):1481-8
PMID: 9704648
-
Perturbation of the T cell repertoire in rheumatoid arthritis.
Proc Natl Acad Sci U S A. 1998 Nov 24;95(24):14447-52
PMID: 9826720
-
Detection of human retrovirus 5 in patients with arthritis and systemic lupus erythematosus.
Arthritis Rheum. 1999 Mar;42(3):448-54
PMID: 10088767
-
Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group.
N Engl J Med. 2000 Nov 30;343(22):1594-602
PMID: 11096166